ICH Q5C: Quality of Biotechnological Products Stability Testing of Biotechnological/Biological Products
In early comparisons, a leading dual-receptor peptide reduced body weight by about 20%, which is already a massive effect
Clegg LE, Penland RC, Bachina S et al (2019) Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial
Just because its online and its accessible and it can be sold without a prescription, does not mean its authentic. This article is exclusive to STAT+ subscribers Unlock this article and get additional analysis of the technologies disrupting health care by subscribing to STAT+
Solid-phase peptide synthesis (SPPS) requires significant solvent volumes
A 2026 Cambridge University study found GLP-1 patients receive zero nutritional guidance, leaving critical gaps that silently undermine the results you're working so hard for
